摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3-{[tert-butyl(dimethyl)silyl]oxy}-4,6,7-trimethyl-1-benzofuran-5-yl)-4-(4-methoxyphenyl)piperazine | 1243544-70-8

中文名称
——
中文别名
——
英文名称
1-(3-{[tert-butyl(dimethyl)silyl]oxy}-4,6,7-trimethyl-1-benzofuran-5-yl)-4-(4-methoxyphenyl)piperazine
英文别名
1-(3-{[tert-butyl(dimethyl)silyl]oxy}-4,6,7-trimethyl-benzofuran-5-yl)-4-(4-methoxyphenyl)piperazine;tert-butyl-[[5-[4-(4-methoxyphenyl)piperazin-1-yl]-4,6,7-trimethyl-1-benzofuran-3-yl]oxy]-dimethylsilane
1-(3-{[tert-butyl(dimethyl)silyl]oxy}-4,6,7-trimethyl-1-benzofuran-5-yl)-4-(4-methoxyphenyl)piperazine化学式
CAS
1243544-70-8
化学式
C28H40N2O3Si
mdl
——
分子量
480.723
InChiKey
HYOVWFWASHRWDD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.08
  • 重原子数:
    34
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    38.1
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Benzofuran derivatives
    申请人:Tsukamoto Tetsuya
    公开号:US20100234357A1
    公开(公告)日:2010-09-16
    The present invention provides a compound represented by the following formula (I): wherein: Ring A represents an optionally substituted piperazine ring, an optionally substituted morpholine ring, or an optionally substituted homopiperazine ring; R 1 and R 2 are the same or different from each other, and represent a hydrogen atom or optionally substituted lower alkyl; R 3 and R 4 are the same or different from each other, and represent a hydrogen atom or halogenated or non-halogenated lower alkyl; R 5 to R 7 are the same or different from each other, and represent a hydrogen atom, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted lower alkoxy, optionally substituted cycloalkyl, optionally substituted aryl, an optionally substituted aromatic heterocyclic ring, optionally substituted amino, or acyl; and represents a single bond or double bond, or a salt thereof.
    本发明提供了一种由以下式(I)表示的化合物: 其中: 环A代表可选择地取代的哌嗪环、可选择地取代的吗啉环或可选择地取代的同环丙二胺环; R1和R2彼此相同或不同,代表氢原子或可选择地取代的较低烷基; R3和R4彼此相同或不同,代表氢原子或卤代或非卤代的较低烷基; R5到R7彼此相同或不同,代表氢原子、羟基、可选择地取代的较低烷基、可选择地取代的较低烯基、可选择地取代的较低烷氧基、可选择地取代的环烷基、可选择地取代的芳基、可选择地取代的芳香杂环、可选择地取代的氨基或酰基;和 代表单键或双键,或其盐。
  • BENZOFURAN DERIVATIVES
    申请人:Tsukamoto Tetsuya
    公开号:US20120232096A1
    公开(公告)日:2012-09-13
    The present invention provides a compound represented by the following formula (I): wherein: Ring A represents an optionally substituted piperazine ring, an optionally substituted morpholine ring, or an optionally substituted homopiperazine ring; R 1 and R 2 are the same or different from each other, and represent a hydrogen atom or optionally substituted lower alkyl; R 3 and R 4 are the same or different from each other, and represent a hydrogen atom or halogenated or non-halogenated lower alkyl; R 5 to R 7 are the same or different from each other, and represent a hydrogen atom, hydroxy, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted lower alkoxy, optionally substituted cycloalkyl, optionally substituted aryl, an optionally substituted aromatic heterocyclic ring, optionally substituted amino, or acyl; and represents a single bond or double bond, or a salt thereof.
    本发明提供一种由以下式(I)表示的化合物:其中:环A表示可选取代的哌嗪环、可选取代的吗啡环或可选取代的同源哌嗪环;R1和R2相同或不同,表示氢原子或可选取代的低碳基;R3和R4相同或不同,表示氢原子或卤化或非卤化的低碳基;R5至R7相同或不同,表示氢原子、羟基、可选取代的低碳基、可选取代的低碳烯基、可选取代的低碳氧基、可选取代的环烷基、可选取代的芳基、可选取代的芳香杂环环、可选取代的氨基或酰基;表示单键或双键,或其盐。
  • Discovery of Benzofuran Derivatives that Collaborate with Insulin-Like Growth Factor 1 (IGF-1) to Promote Neuroprotection
    作者:Takeshi Wakabayashi、Norihito Tokunaga、Kazuyuki Tokumaru、Taiichi Ohra、Nobuyuki Koyama、Satoru Hayashi、Ryuji Yamada、Mikio Shirasaki、Yoshitaka Inui、Tetsuya Tsukamoto
    DOI:10.1021/acs.jmedchem.6b00191
    日期:2016.5.26
    A series of benzofuran derivatives with neuroprotective activity in collaboration with IGF-1 was discovered using a newly developed cell-based assay involving primary neural cells prepared from rat hippocampal and cerebral cortical tissues. A structure activity relationship study identified compound 8 as exhibiting potent activity and brain penetrability. An in vitro pharmacological study demonstrated that although IGF-1 and 8 individually exhibited the neuroprotective effect, the latter acted in collaboration with IGF-1 to enhance neuroprotective activity.
查看更多